Why Cortisone Shots Make Heel Pain Worse

That first step out of bed — the white-hot blade through the heel — is one of the most recognizable pains in medicine. It is also one of the most consistently misunderstood. If you have had a cortisone shot for it, there is something you were probably never told: in chronic cases, the injection may be working against the tissue it was meant to rescue.

Fasciitis or fasciosis? The distinction that changes everything

The suffix -itis means inflammation. That is the assumption baked into the name “plantar fasciitis,” and it is the assumption that justifies an anti-inflammatory injection.

But in chronic cases, that assumption does not hold. What is actually present is plantar fasciosis — not an active inflammatory process, but a degenerative breakdown of the tissue itself. The fascia is not inflamed and angry; it is failing and disorganized.

This is not a semantic quibble. The two conditions call for opposite interventions. One calls for calming a fire. The other calls for rebuilding a structure. Treating the second as though it were the first is where the trouble begins.

Why cortisone works against degenerating tissue

Cortisone is a catabolic agent — it breaks tissue down rather than building it up. Specifically, it:

• Halts collagen synthesis — the exact process a degenerating fascia depends on to repair itself
• Shuts down repair cells — the cellular machinery of healing goes quiet
• Chokes off blood flow — reducing the delivery of oxygen and nutrients to tissue already struggling

The result is a few weeks of genuine, welcome relief while the underlying structure is quietly dismantled. The pain signal is suppressed; the problem generating it is not. This is why the second shot often does less than the first, and the third less than the second.

The documented risks of repeated injections

This is not a theoretical concern. Peer-reviewed data links repeated steroid injections to two specific and serious outcomes:

Complete rupture of the plantar fascia. The structure can fail outright — converting a painful but intact foot into a mechanically compromised one.

Heel fat-pad atrophy. The natural cushion beneath the heel bone thins and wastes. Once that shock absorber is gone, the calcaneus bears load directly, and that loss is not easily reversed.

Both are the kind of harm that is difficult to undo — which is why the decision to repeat an injection deserves more scrutiny than it usually receives.

The surgical option deserves the same scrutiny

When injections stop working, fasciotomy is often the next offer. The results warrant caution: up to 50% of patients report being unsatisfied after the procedure, and cutting the fascia can flatten the arch it was structurally supporting — trading a heel problem for a foot-mechanics problem.

What treating the actual problem looks like

If the fascia is degenerating, the goal is to rebuild it. At Regen.MD that means several things working together:

Orthobiologic therapies — platelet-rich plasma (PRP), microfragmented adipose tissue, and platelet lysate — aim to deliver repair signaling into tissue that has stopped repairing itself. On the comparison that matters most, PRP has outperformed cortisone at 6, 12, and 18 months — the reverse of cortisone’s front-loaded, fading curve.

Ultrasound guidance, not blind injection. Sub-millimeter placement into a specific degenerative lesion is a different intervention from a landmark-based shot, however experienced the hand.

Metabolic preparation first. An injection is an instruction, and a body in metabolic disarray cannot execute it. Optimizing the terrain — the inflammatory and metabolic environment the tissue lives in — is what makes the biology capable of responding at all. This is the principle behind everything we do, and it is why evaluation precedes intervention.

Which of these applies to your foot is a clinical question, not a website question. It requires imaging, examination, and a look at your metabolic markers.

Frequently asked questions

Key takeaways

• Chronic heel pain is usually plantar fasciosis — degeneration — not active inflammation.
• Cortisone is catabolic: it halts collagen synthesis, suppresses repair cells, and reduces blood flow.
• Repeated steroid injections are linked to plantar fascia rupture and heel fat-pad atrophy.
• Fasciotomy carries meaningful dissatisfaction rates and can flatten the arch.
• Orthobiologic therapy with ultrasound guidance, on a prepared metabolic terrain, targets the degeneration itself — and PRP has outperformed cortisone at 6, 12, and 18 months.

Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician. Orthobiologic therapies including PRP and microfragmented adipose tissue are not FDA-approved for this indication and are provided as part of physician-directed care.